Study finds increased risk of fatal complications for patients from every minority ethnic background after donor stem cell transplant
Black and Asian cancer patients are less likely to survive in the five years after a donor stem cell transplant than their white counterparts, according to a study and largest of its kind.
The study, published in Lancet Haematology, looked at 30,000 patients who had a stem cell transplant between 2009 and 2020 on the NHS, with 19,000 of these being cancer patients.
